+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Middle East and Africa Hemodialysis and Peritoneal Dialysis Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Type, Product, and End User

  • PDF Icon

    Report

  • 109 Pages
  • September 2022
  • Region: Africa, Middle East
  • The Insight Partners
  • ID: 5668110
UP TO OFF until Mar 31st 2024
The hemodialysis and peritoneal dialysis market in the Middle East & Africa is expected to grow from US$ 5,543.84 million in 2022 to US$ 7,105.17 million by 2028; it is estimated to grow at a CAGR of 4.2% from 2022 to 2028.

Various market strategies by key players are driving the Middle East & Africa hemodialysis and peritoneal dialysis market. The hemodialysis and peritoneal dialysis market is characterized by the presence of big and small companies. Players are adopting strategies such as product launches, regional expansions, and technological advancements to increase their market share. Continuous innovations and technological advancements are resulting in the introduction of safer and more effective hemodialysis and peritoneal dialysis, leading to increased acceptance among patients and medical societies.

A few recent developments related to hemodialysis and peritoneal dialysis are mentioned below.
  • In May 2021, Mar Cor Purification, Inc., a Cantel Medical Corp. business, announced the launch of the EON Portable Dialysis Water System. The portable water purification device uses reverse osmosis (RO) to remove organic and inorganic substances and microbial contaminants from water that feeds into hemodialysis machines to treat hemodialysis patients or related therapies. The water system quickly delivers and efficiently produces medical-grade water for single-patient hemodialysis treatments in hospitals, clinics, skilled nursing centers, and home environments.
In May 2021, DaVita Inc. expanded its home kidney care program to include the HomeChoice Claria Automated Peritoneal Dialysis (APD) system enabled by Sharesource remote patient monitoring from Baxter International Inc. This new technology further enhanced DaVita's home dialysis program and is another important step forward to enable more patients to choose to treat their kidney failure at home.
Such developments and launches of new products are likely to bring new trends in the hemodialysis and peritoneal dialysis market in the coming years.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the Middle East & Africa hemodialysis and peritoneal dialysis market. The Middle East & Africa hemodialysis and peritoneal dialysis market is expected to grow at a good CAGR during the forecast period.

Middle East & Africa Hemodialysis and Peritoneal Dialysis Market Segmentation

The Middle East & Africa hemodialysis and peritoneal dialysis market is segmented into type, product, end user, and country.
  • Based on type, the market is bifurcated into hemodialysis and peritoneal dialysis. In 2022, the hemodialysis segment is expected to hold a larger market share.
  • Based on product, the hemodialysis and peritoneal dialysis market is segmented into devices, consumables, and services. The services segment is likely to hold the largest market share in 2022.
  • Based on end user, the market is segmented into hospital-based and home-based. The hospital-based segment is expected to account for a larger share in 2022.
  • Based on country, the Middle East & Africa hemodialysis and peritoneal dialysis market is segmented into Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa. Saudi Arabia is expected to hold the largest market share in 2022.
B. Braun Melsungen AG; Baxter International Inc.; DaVita Inc.; Dialife SA; Diaverum; Fresenius Medical Care AG & Co KGaA; and Nipro Medical Corporation are among the leading companies operating in the Middle East & Africa hemodialysis and peritoneal dialysis market.
Frequently Asked Questions about the Middle Eastern and African Hemodialysis and Peritoneal Dialysis Market

What is the estimated value of the Middle Eastern and African Hemodialysis and Peritoneal Dialysis Market?

The Middle Eastern and African Hemodialysis and Peritoneal Dialysis Market was estimated to be valued at $5543.84 Million in 2022.

What is the growth rate of the Middle Eastern and African Hemodialysis and Peritoneal Dialysis Market?

The growth rate of the Middle Eastern and African Hemodialysis and Peritoneal Dialysis Market is 4.2%, with an estimated value of $7105.17 Million by 2028.

What is the forecasted size of the Middle Eastern and African Hemodialysis and Peritoneal Dialysis Market?

The Middle Eastern and African Hemodialysis and Peritoneal Dialysis Market is estimated to be worth $7105.17 Million by 2028.

Who are the key companies in the Middle Eastern and African Hemodialysis and Peritoneal Dialysis Market?

Key companies in the Middle Eastern and African Hemodialysis and Peritoneal Dialysis Market include B. Braun Melsungen AG, Baxter International Inc., DaVita Inc., Dialife SA, Diaverum, Fresenius Medical Care AG & Co KGaA and Nipro Medical Corporation.

Table of Contents

1. Introduction
1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 MEA Hemodialysis and Peritoneal Dialysis Market - By Type
1.3.2 MEA Hemodialysis and Peritoneal Dialysis Market - By Product
1.3.3 MEA Hemodialysis and Peritoneal Dialysis Market - By End User
1.3.4 MEA Hemodialysis and Peritoneal Dialysis Market - By Country
2. MEA Hemodialysis and Peritoneal Dialysis Market - Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. MEA Hemodialysis and Peritoneal Dialysis Market - Market Landscape
4.1 Overview
4.2 MEA PEST Analysis
4.3 Expert Opinion
5. MEA Hemodialysis and Peritoneal Dialysis Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Kidney Diseases Becoming More Common
5.1.2 Rising Cases of Diabetes
5.2 Market Restraints
5.2.1 Risks and Complications with Dialysis
5.3 Market Opportunities
5.3.1 Home Care Dialysis Becoming More Popular Among Patients
5.4 Future Trends
5.4.1 Various Market Strategies by Key Players
5.5 Impact Analysis
6. Haemodialysis and Peritoneal Dialysis Market- MEA Analysis
6.1 MEA Haemodialysis and Peritoneal Dialysis Market Revenue Forecast and Analysis
6.2 MEA Haemodialysis and Peritoneal Dialysis Market, By Country - Forecast and Analysis
7. MEA Haemodialysis and Peritoneal Dialysis Market Revenue and Forecasts To 2028- by Type
7.1 Overview
7.2 MEA Haemodialysis and Peritoneal Dialysis Market, By Type, 2022 & 2028 (%)
7.3 Haemodialysis
7.3.1 Overview
7.3.2 Haemodialysis: Haemodialysis and Peritoneal Dialysis Market Revenue and Forecasts to 2028 (US$ Million)
7.4 Peritoneal Dialysis
7.4.1 Overview
7.4.2 Peritoneal Dialysis: Haemodialysis and Peritoneal Dialysis Market Revenue and Forecasts to 2028 (US$ Million)
8. MEA Haemodialysis and Peritoneal Dialysis Market Revenue and Forecasts To 2028 - Product
8.1 Overview
8.2 MEA Haemodialysis and Peritoneal Dialysis Market Share by Product Segment - 2021 & 2028 (%)
8.3 Devices
8.3.1 Overview
8.3.2 Devices: Haemodialysis and Peritoneal Dialysis Market Revenue and Forecast to 2028 (US$ Million)
8.4 Consumables
8.4.1 Overview
8.4.2 Consumables: Haemodialysis and Peritoneal Dialysis Market Revenue and Forecast to 2028 (US$ Million)
8.5 Services
8.5.1 Overview
8.5.2 Services: Haemodialysis and Peritoneal Dialysis Market Revenue and Forecast to 2028 (US$ Million)
9. MEA Haemodialysis and Peritoneal Dialysis Market Revenue and Forecasts To 2028 - End User
9.1 Overview
9.2 MEA Haemodialysis and Peritoneal Dialysis Market Share by End User Segment - 2021 & 2028 (%)
9.3 Hospital-Based
9.3.1 Overview
9.3.2 Hospital-Based: Haemodialysis and Peritoneal Dialysis Market Revenue and Forecast to 2028 (US$ Million)
9.4 Home-Based
9.4.1 Overview
9.4.2 Home-Based: Haemodialysis and Peritoneal Dialysis Market Revenue and Forecast to 2028 (US$ Million)
10. MEA Haemodialysis and Peritoneal Dialysis Market Revenue and Forecasts to 2028 - Country Analysis
10.1 Overview
10.1.1 MEA Hemodialysis and Peritoneal Dialysis Market Revenue and Forecast to 2028, by Country (%)
10.1.1.1 UAE: Hemodialysis and Peritoneal Dialysis Market Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.1 UAE: Hemodialysis and Peritoneal Dialysis Market Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.2 UAE: Hemodialysis and Peritoneal Dialysis Market Revenue and Forecast to 2028, by Type (US$ Million)
10.1.1.1.3 UAE: Hemodialysis and Peritoneal Dialysis Market Revenue and Forecast to 2028, by Product (US$ Million)
10.1.1.1.4 UAE: Hemodialysis and Peritoneal Dialysis Market, by End User- Revenue and Forecast to 2028 (US$ Million)
10.1.1.2 Saudi Arabia: Hemodialysis and Peritoneal Dialysis Market Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.1 Saudi Arabia: Hemodialysis and Peritoneal Dialysis Market Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.2 Saudi Arabia: Hemodialysis and Peritoneal Dialysis Market Revenue and Forecast to 2028, by Type (US$ Million)
10.1.1.2.3 Saudi Arabia: Hemodialysis and Peritoneal Dialysis Market Revenue and Forecast to 2028, by Product (US$ Million)
10.1.1.2.4 Saudi Arabia: Hemodialysis and Peritoneal Dialysis Market, by End User- Revenue and Forecast to 2028 (US$ Million)
10.1.1.3 South Africa: Hemodialysis and Peritoneal Dialysis Market Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.1 South Africa Hemodialysis and Peritoneal Dialysis Market Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.2 South Africa: Hemodialysis and Peritoneal Dialysis Market Revenue and Forecast to 2028, by Type (US$ Million)
10.1.1.3.3 South Africa: Hemodialysis and Peritoneal Dialysis Market, by Product - Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.4 South Africa: Hemodialysis and Peritoneal Dialysis Market, by End User - Revenue and Forecast to 2028 (US$ Million)
10.1.1.4 Rest of MEA: Hemodialysis and Peritoneal Dialysis Market Revenue and Forecast to 2028 (US$ Million)
10.1.1.4.1 Rest of MEA: Hemodialysis and Peritoneal Dialysis Market Revenue and Forecast to 2028 (US$ Million)
10.1.1.4.2 Rest of MEA: Hemodialysis and Peritoneal Dialysis Market Revenue and Forecast to 2028, by Type (US$ Million)
10.1.1.4.3 Rest of MEA: Hemodialysis and Peritoneal Dialysis Market Revenue and Forecast to 2028, by Product (US$ Million)
10.1.1.4.4 Rest of MEA: Hemodialysis and Peritoneal Dialysis Market, by End User - Revenue and Forecast to 2028 (US$ Million)
11. Hemodialysis and Peritoneal Dialysis Market-Industry Landscape
11.1 Overview
11.2 Growth Strategies in the Hemodialysis and Peritoneal Dialysis Market (%)
11.3 Organic Developments
11.3.1 Overview
11.4 Inorganic Developments
11.4.1 Overview
12. Company Profiles
12.1 Fresenius Medical Care AG & Co KGaA
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 DaVita Inc.
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Baxter International Inc.
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 B. Braun Melsungen AG
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Diaverum
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Nipro Medical Corporation
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Dialife SA
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
13. Appendix
13.1 About the Publisher
13.2 Glossary of Terms

Companies Mentioned

A selection of companies mentioned in this report includes:

  • B. Braun Melsungen AG
  • Baxter International Inc.
  • DaVita Inc.
  • Dialife SA
  • Diaverum
  • Fresenius Medical Care AG & Co KGaA
  • Nipro Medical Corporation